December 31, 2009
But medical device giant doesn't admit wrongdoing.
Finds that 65 percent of devices were supported by one study; FDA questions research methods.
Deal takes criminal charges off the table.
Investigation targets companies’ most profitable products
Says device tax would result in ‘unintended consequences’
Executives claim move is key part of Mesa’s growth strategy
Expansion improves company's capacity, workflow and output
New division will have its own staff
Company attempting to offset declining sales with second major acquisition in seven months
Company prepares for orthopedic sector recovery
Start date moved to 2011.
Change would lessen impact on small companies
Company hopes to have ten sites in U.S. and Israel by year's end
Merger increases DePuy's selection of hip-bearing offerings
Martin Rothman has served as director of cardiac research and development at London Chest Hospital.
Senator sends letter to 33 medical organizations.
Allegations involve improper payments to Greek healthcare officials.
But spinoff Data Sciences International Inc. remains in business.
Agency said it received reports of malfunctions
Michael Coyle previously worked for St. Jude Medical as president of Cardiac Rhythm Management.
Indiana-based firm has 15 days to respond to agency.
All domestic units have been repaired, the firm said.
Groundbreaking is planned for the fourth quarter of this year.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.